Evidence map›Paper›PMID 30587176›Full record

ArticleBMC psychiatry2018

Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning.

Anne E Ferrey, Galit Geulayov, Deborah Casey, Claudia Wells, Alice Fuller, Clare Bankhead, Jennifer Ness, Caroline Clements, David Gunnell, Navneet Kapur and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pharmacological interventions for self-harm in adults.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Anne E FerreyCentre for Suicide Research, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. anne.ferrey@phc.ox.ac.uk.ORCID 0000-0002-5644-2735
Galit GeulayovCentre for Suicide Research, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Deborah CaseyCentre for Suicide Research, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Claudia WellsOffice for National Statistics, Newport, UK.
Alice FullerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Clare BankheadNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Jennifer NessCentre for Self-harm and Suicide Prevention Research, Derbyshire Healthcare NHS Foundation Trust, Derby, UK.
Caroline ClementsCentre for Suicide Prevention, University of Manchester, Manchester, UK.
David GunnellSchool of Social and Community Medicine, University of Bristol, Bristol, UK.
Navneet KapurCentre for Suicide Prevention, University of Manchester, Manchester, UK.
Keith HawtonCentre for Suicide Research, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Warneford Hospital · GBUniversity of Manchester · GBUniversity of Oxford · GBDerbyshire Community Health Services NHS Foundation Trust · GBOffice for National Statistics · GBUniversity of Bristol · GB

Funding

Department of Health RP-PG-0610-10026
6 · The paper itself

Abstract

backgroundBipolar and other psychiatric disorders are associated with considerably increased risk of suicidal behaviour, which may include self-poisoning with medication used to treat the disorder. Therefore, choice of medication for treatment should include consideration of toxicity, especially for patients at risk. The aim of this study was to estimate the relative toxicity of specific drugs within two drug categories, antipsychotics and mood stabilizers, using large-scale databases to provide evidence that could assist clinicians in making decisions about prescribing, especially for patients at risk of suicidal behaviour.

methodTwo indices were used to assess relative toxicity of mood stabilisers and antipsychotics: case fatality (the ratio between rates of fatal and non-fatal self-poisoning) and fatal toxicity (the ratio between rates of fatal self-poisoning and prescription). Mood stabilisers assessed included lithium [reference], sodium valproate, carbamazepine, and lamotrigine, while antipsychotics included chlorpromazine [reference], clozapine, olanzapine, quetiapine and risperidone. Fatal self-poisoning (suicide) data were provided by the Office for National Statistics (ONS), non-fatal self-poisoning data by the Multicentre Study of Self-harm in England, and information on prescriptions by the Clinical Practice Research Datalink. The primary analysis focussed on deaths due to a single drug. Cases where the drug of interest was listed as the likely primary toxic agent in multiple drug overdoses were also analysed. The study period was 2005-2012.

resultsThere appeared to be little difference in toxicity between the mood stabilisers, except that based on case fatality where multiple drug poisonings were considered, carbamazepine was over twice as likely to result in death relative to lithium (OR 2.37 95% CI 1.16-4.85). Of the antipsychotics, clozapine was approximately18 times more likely to result in death when taken in overdose than chlorpromazine (single drug case fatality: OR 18.53 95% CI 8.69-39.52). Otherwise, only risperidone differed from chlorpromazine, being less toxic (OR 0.06 95% CI 0.01-0.47).

conclusionsThere was little difference in toxicity of the individual mood stabilisers. Clozapine was far more toxic than the other antipsychotics. The findings are relevant to prescribing policy, especially for patients at particular risk of suicidal behaviour.

Indexed as

Antipsychotic AgentsDrug OverdoseMedication Therapy ManagementMental DisordersSelf-Injurious BehaviorSuicideSuicide PreventionTranquilizing AgentsAdultEnglandFemaleHumansPractice Patterns, Physicians'Risk AdjustmentAntipsychotic AgentsTranquilizing AgentsAntipsychoticsDrug toxicityMood stabilisersSelf-poisoningSuicide

Identifiers

PMID30587176
PMCPMC6307121
OpenAlexW2905692276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.